1. Introduction {#s0005}
===============

Bipolar disorder (BD) is a debilitating psychiatric disorder that causes morbidity and disability worldwide throughout the lifespan ([@bb0100]; [@bb0245]). Despite continuous research efforts, the neurobiological mechanism of BD remains unclear ([@bb0065]; [@bb0200]). However, noninvasive brain imaging such as structural magnetic resonance imaging (sMRI) has successfully characterized BD with wide range brain abnormalities ([@bb0145]).

In the recent large cohort meta-analysis of sMRI studies, the ENIGMA (Enhancing Neuro Imaging Genetics Through Meta-Analysis) bipolar working group identified consistent and robust subcortical volume differences including smaller hippocampus, thalamus and enlarged lateral ventricles ([@bb0140]), and thinner frontal, temporal and parietal cortex ([@bb0145]) in patients compared to controls. These differences show overlap with volumetric differences also found in schizophrenia (SZ) but are not as marked ([@bb0320]; [@bb0325]; [@bb0385]); they are also similar but not identical to differences found in major depressive disorders (MDD) ([@bb0420]).

BD patients can exhibit a wide range of cognitive deficits and symptoms, which overlap with other psychiatric disorders ([@bb0155]; [@bb0410]). Various cognitive domain deficits have been related to corresponding brain regions in BD ([@bb0090]; [@bb0110]; [@bb0180]; [@bb0185]; [@bb0360]). The clinically observed behaviors and symptoms are even more difficult to explore, and yield inconsistent findings ([@bb0355]; [@bb0420]). BD are often studied together with MDD for mood symptoms or together with the schizophrenia spectrum for psychosis symptoms. Though BD along with MDD commonly show reductions in prefrontal, frontal, temporal and anterior cingulate cortex ([@bb0115]), the relationship with depression severity is unclear and inconsistent ([@bb0420]). Mania, however, shows a close relationship with prefrontal regions, and the onset times of mania leading to reduction of GM ([@bb0005]). Anhedonia severity relates to some shared deficits in the reward system in BD, MDD, and SZ ([@bb0275]; [@bb0310]; [@bb0355]). Similar to SZ, BD subjects show cortical deficits in frontal and temporal regions associated with positive symptoms, and frontal regions also with negative symptoms ([@bb0130]; [@bb0280]; [@bb0370]). However, many of these associations are inconsistent due to the disorders\' heterogeneity, both in terms of brain structural underpinnings ([@bb0425]) and clinical symptoms ([@bb0270]). Considering the complexity, it is important to study the patients\' symptoms from a multivariate profile point of view, and the aggregation of regional brain alterations may help to reveal the brain mechanism behind specific symptom profiles ([@bb0210]; [@bb0430]).

To comprehensively assess and create a clinical profile on heterogeneous BD patients and clinical observations, the positive and negative syndrome scale (PANSS) ([@bb0175]) can be an appropriate tool. The PANSS provides a wide range assessment including positive, negative and general symptoms, and it is useful to detect psychotic symptom groups and behavioral traits. In PANSS, the positive symptoms score includes delusions, conceptual disorganization, hallucinations, excitement, grandiosity, suspiciousness, and hostility. The negative scores include blunted affect, emotional withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in abstract thinking, lack of spontaneity and flow of conversation, and stereotyped thinking. Importantly, PANSS has already proved its usefulness in discovering the potential relationship between clinical dimensions and brain alterations ([@bb0190]; [@bb0400]). The PANSS positive symptom severity has been associated with GM concentrations in left perisylvian regions and thalamus, and negative symptom severity with orbitofrontal, prefrontal, temporal and limbic regions in SZ ([@bb0190]). However, a study using the functional connectome identified the fronto-parietal control network and sensorimotor regions to be associated with PANSS positive in SZ, while in BD it is the visual and default mode network ([@bb0400]). The inclusion of PANSS in previous studies, however, are often still limited to the originally designed positive, negative and general subscales ([@bb0390]; [@bb0395]).

Here, we employ parallel independent component analysis (pICA) to reveal the relationship between clinical profiles and the structural brain patterns of BD patients. pICA is a higher order statistical method which can be used to establish association between different data modalities ([@bb0025]; [@bb0035]; [@bb0215]; [@bb0230]; [@bb0290]). Single-modality ICA identifies maximally independent components through blind source separation in one data modality. pICA performs individual ICA on two data modalities simultaneously, and it aims to maximize independence in each modality while optimizing the correlation between the components from both modalities. The output of pICA provides the correlation between two modalities, and loading coefficients of both modalities are calculated for each subject which indicate the contribution of the generated pattern to the subject\'s original data. This blind source separation proceeds automatically, and no prior knowledge and intervention needs be taken into account for this analytical method ([@bb0105]). Previous pICA analysis in SZ has provided a mapping of symptom profiles onto the brain structures, and a distinct PANSS profile characterized by delusions, suspiciousness, hallucinations, and anxiety was associated with GM concentration patterns including inferior temporal gyrus, fusiform gyrus and the sensorimotor cortex ([@bb0240]).

In this study, pICA was performed on GM concentration and PANSS items scores obtained from 110 BD patients. We hypothesized that pICA would identify multimodal components reflecting the joint variance between specific PANSS profiles and distinct structural brain patterns. Specifically, based on the studies reviewed above, we hypothesized that pICA would reveal patterns implicating persistent behavioral deficits and fronto-parietal brain networks.

2. Materials and methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

This study used data from 110 patients with bipolar I (*n* = 69) or II (*n* = 41) diagnoses from the Thematically Organized Psychosis (TOP) study at the Norwegian Centre for Mental Disorders Research (NORMENT) in Oslo, Norway ([@bb0325]; [@bb0330]). All data were collected with approval from the local institutional review board, and all participants signed informed consent. Patients met following criteria to be included in the study: 1) aged from 18 to 65 years; 2) understood and spoke a Scandinavian language; 3) had no history of severe head trauma; 4) had IQ over 70. The diagnosis of bipolar I (DSM-IV 296.0-7) and bipolar 2 (DSM-IV 296.89) was established by the Structured Clinical Interview for DSM-IV Axis I Disorders. At the stage of enrollment, the mood status of the patients was identified as depressive (*n* = 60), manic (*n* = 5), euthymic (*n* = 40), mixed (*n* = 2) and unspecified (*n* = 3). In addition, 54 patients (approximately 50%) experienced at least one lifetime psychotic episode. PANSS scores and structural MRI data were available for all the participants, and detailed demographic and scanning information are presented in [Table 1](#t0005){ref-type="table"}.Table 1Demographic and scanning information, *N* = 110.Table 1MeanSDAge(years)34.8711.65Females (N/%)72 (65%)Duration of illness(years)12.1310.09PANSS positive score9.813.28PANSS negative score9.753.54PANSS general score25.425.82PANSS total score44.9610.33Field strength (T)1.5SequenceMPRAGEVoxel size (mm)1.33 × 0.94 × 1Scanning orientationSagittal[^1]

2.2. Positive and negative symptom scores (PANSS) {#s0020}
-------------------------------------------------

All participants provided complete PANSS item scores, which included all 30 items of PANSS with positive, negative and general symptom dimensions.

2.3. Neuroimaging acquisition and preprocessing {#s0025}
-----------------------------------------------

All patients were scanned on a 1.5 T Siemens Magnetom Sonata scanner (Siemens Medical Solutions, Erlangen, Germany) scanner. T1-weighted structural MRI data were collected using a MPRAGE sequence. T1-weighted images were normalized to the standard Montreal Neurological Institute (MNI) template using a 12-parameter affine model, resliced to a voxel size of 2 × 2 × 2 mm and segmented into GM, white matter, and cerebro-spinal fluid using Statistical Parametric Mapping 12 (SPM12, <http://www.fil.ion.ucl.ac.uk/spm/software/spm12/>). To identify possible outliers, individual scans were correlated with group GM template, and the correlation was computed. One subject showing low correlation with the group GM template (ρ \< 0.98) was excluded. 109 participants were included in following analysis. Voxel-wise regression of age and gender was performed to remove their possible effects. Structural MRI data were smoothed with a 10 mm full width at half maximum Gaussian kernel ([@bb0105]).

2.4. Parallel independent component analysis (pICA) {#s0030}
---------------------------------------------------

Fusion ICA Toolbox (FIT, <http://mialab.mrn.org/software/fit/>) was employed to perform pICA on the preprocessed structural images and PANSS item scores. The optimal component number of structural MRI data was estimated to be 25 by the minimum description length (MDL) algorithm ([@bb0335]). The components for PANSS items was set to three according to its inner structure (positive, negative and general symptom dimensions). A GM mask was applied on structural images before ICA was performed. To ensure stability of component estimation, infomax ICA was run 20 times, and the central point of 20 runs was selected as the final component using ICASSO ([@bb0150]). Using the default setting of pICA, three components in each modality were constrained to be optimized ([@bb0215]). More specifically, the correlation between the loading coefficients of sMRI and PANSS was optimized through pICA while independence within each modality was further maximized.

2.5. Validations {#s0035}
----------------

After the original pICA analysis, 10-fold cross-validation was performed to ensure that the pICA estimation was not driven by a subset of participants or potential outliers. Each validation run included 90% of the individuals of the sample. Parameter settings of 10-fold validation were essentially the same as the original analysis. The results from each fold were examined for overlap with the original pICA.

2.6. Additional analysis {#s0040}
------------------------

To control possible confounders, duration of illness (DOI) and current medication status were assessed in this study. The current medication status was included as a binary variable according to whether or not the patient was currently on antipsychotic, antiepileptic or lithium treatment ([@bb0135]; [@bb0170]). The medication effect was tested on GM concentrations and PANSS loading coefficients.

The relations of original PANSS subscale scores (positive, negative and general symptoms), PANSS loading coefficients and sMRI loading coefficients from pICA were also assessed.

3. Results {#s0045}
==========

3.1. Parallel independent component analysis {#s0050}
--------------------------------------------

Two pairs of sMRI and PANSS components showed significant correlations, passing the Bonferroni correction threshold of 6.67 × 10^−04^ (determined by 25 sMRI components and 3 PANSS components). In the first pair of components, the correlation between the structural MRI and PANSS components was Pearson\'s *r* = −0.41 (*p* = 7.67 × 10^−06^)([Fig. 1](#f0005){ref-type="fig"}). In the second pair, the correlation was Pearson\'s *r* = −0.35 (*p* = 1.80 × 10^−04^)([Fig. 3](#f0015){ref-type="fig"}). The negative correlation indicated that greater loading coefficients of sMRI correlated with lower loadings of symptom profile represented by PANSS.Fig. 1Negative correlation between loading coefficients of the first PANSS component and sMRI component.Pearson\'s r = −0.41, *P* = 7.67 × 10^−06^ (Bonferroni-corrected threshold = 6.67^−04^).Fig. 1Fig. 3Negative correlation between loading coefficients of the second pair of PANSS component and the sMRI component.Pearson\'s *r* = −0. 35, *P* = 1.80 × 10^−04^ (Bonferroni-corrected threshold = 6.67^−04^).Fig. 3

In the first pair, the sMRI component showed positively contributing GM concentration mainly in right middle/superior temporal gyrus in the more medial aspect (extended to inferior frontal gyrus, see [Fig. 2](#f0010){ref-type="fig"}a and [Table 2](#t0010){ref-type="table"}). The corresponding PANSS component was positively weighted strongly on anxiety (G2), guilty feelings (G3) and depression (G6); the lack of spontaneity and flow of conversation (N6) was negatively associated with this component ([Fig. 2](#f0010){ref-type="fig"}b). Participants with higher preserved GM concentration in right superior/middle temporal gyrus exhibited reduced severity in these symptoms consisting of anxiety, guilty feelings and depression.Fig. 2Parallel ICA results - the first pair -- 'mood' component a) structural MRI and b) PANSS components.PANSS items with \|Z\| \>1: N6 -- Lack of spontaneity and flow of conversation; G2 -- Anxiety; G3 -- Guilty feelings; G6 -- Depression.Fig. 2Table 2Brain regions, peak coordinates and volumes of component 1 and 2.Table 2Brain regionsBrodmann areaVolumes (cc^3^)Peak coordinates (Z and coordinates)Component 1 Cluster 1R superior temporal gyrus (extended to inferior frontal gyrus & insula)483.66.0 (48, 14, −6) Cluster 2R middle temporal gyrus392.77.8 (38, −62, 22)Component 2 Cluster 1/2L/R parietal lobe (postcentral gyrus)3,35.7/5.53.3(−40,-26, 40)/5.5(46, −26, 36) Cluster 3/4L/R frontal lobe (middle frontal gyrus)9,85.4/3.05.4(−26,32,32)/6.4(22, 12, 46) Cluster 5L inferior middle temporal gyrus, posterior373.47.6(−46,-58,-6) Cluster 6L inferior parietal lobule412.97.6(−46,-46,22) Cluster 7L parietal lobe (L angular gyrus)72.77.3(−30,-60,38) Cluster 8L supramarginal gyrus404.6−7.3(−42,-46,38)[^2]

In the second pair, positively contributing GM concentration was mainly located in bilateral middle frontal gyrus, bilateral parietal lobule including postcentral gyrus with temporal regions on the left side (left inferior, middle and superior temporal gyrus), and negatively contributing GM concentration was located in left supramarginal gyrus for the sMRI component (see [Fig. 4](#f0020){ref-type="fig"}a and [Table 2](#t0010){ref-type="table"}). The PANSS component was positively weighted strongly on blunted affect (N1), emotional withdrawal (N2), passive/apathetic social withdrawal (N4), depression (G6) and active social avoidance (G16), and excitement (P4) and guilty feeling (G3) was negatively associated with this component ([Fig. 4](#f0020){ref-type="fig"}b). In summary, participants with higher preserved GMC in bilateral frontal, parietal and left temporal regions show milder severity for these symptoms.Fig. 4Parallel ICA results - the second pair -- 'apathy' component a) structural MRI and b) PANSS components.PANSS items with \|Z\| \>1: P4 -- Excitement; N1 -- Blunted affect; N2 -- Emotional withdrawal; N4 -- Passive/apathetic social withdrawal; G3 -- Guilty feelings; G6 -- Depression;G16 -- Active social avoidance.Fig. 4

3.2. 10-Fold validation {#s0055}
-----------------------

The 10-fold validation showed high correlation with the original pICA results in both of the pairs of components. For the first pair, 7 out of 10 validation runs showed similar results to the original output, with one of run showing an inverted direction of sMRI and PANSS correlation to the other runs. The first pair presented a mean correlation of Pearson\'s *r* = 0.75 of above replicated runs. The second pair also presented similar stability, with 7 out of 10 validation runs showing similar results to the original output and two of the runs showing inverted direction of sMRI and PANSS correlation to the other runs. The second pair presented a mean correlation of Pearson\'s *r* = 0.67 of its replicated runs.

3.3. Additional analysis {#s0060}
------------------------

In the regression model including loadings coefficients of sMRI components as dependent variable and DOI values as predictors, there was no significant association between the DOI and component 1 (β = −0.10, *t* = −1.06, *p* = .29) or component 2 (β = −0.004, *t* = −0.043, *p* = .97). The regression model including loadings coefficients of PANSS components as dependent variable and DOIs as predictors also showed no significant association in component 1 (β = 0.01, *t* = 0.08, *p* = .94) or component 2 (β = −0.05, *t* = −0.49, *p* = .63).

There was no significant correlation between medication status and the sMRI loading coefficients in component 1 (Spearman\'s ρ = 0.10, *p* = .33) or component 2 (Spearman\'s ρ = −0.06, *p* = .56). In addition, there was no significant correlation between medication status and the PANSS loading coefficients in component 1 (Spearman\'s ρ = −0.06, *p* = .57) or component 2 (Spearman\'s ρ = −0.14, *p* = .88).

In the first pair, the correlation between the original PANSS subscale scores and the pICA derived PANSS loading coefficients revealed no association with PANSS positive (Pearson\'s *r* = 0.017, *p* = .86), negative (Pearson\'s *r* = 0.15, p = .88), or general (Pearson\'s *r* = 0.062, *p* = .53) scores. In addition, sMRI component loading coefficients were not significantly correlated with PANSS positive (Pearson\'s *r* = 0.023, *p* = .82), negative (Pearson\'s *r* = −0.039, *p* = .69), and general (Pearson\'s *r* = −0.031, *p* = .75) scores.

In the second pair, there was also no significant correlation found between the pICA PANSS component loading and PANSS positive (Pearson\'s *r* = 0.074, *p* = .45), negative (Pearson\'s *r* = 0.11, *p* = .27), or general (Pearson\'s r = 0.11, *p* = .26) scores. In the sMRI, the loading coefficients were not significantly correlated with PANSS positive (Pearson\'s *r* = 0.072, p = .45), negative (Pearson\'s r = −0.031, p = .75) and general (Pearson\'s *r* = −0.061, p = .53) scores.

4. Discussion {#s0065}
=============

In this study, we find two gray matter networks that relate to two different patterns of symptom severity in a large BP sample. Importantly, the PANSS profiles highlighted here were not constructed according to the typical PANSS subscales, but were driven by the underlying relationships with gray matter patterns. The mood profile was correlated with reductions in the right temporal gyrus, while the apathy/asocial profile correlated with a more widespread network including frontal, temporal and parietal regions. It implicated the GM deficits in regional temporal lobe and frontal-temporal-parietal circuits that were separately related to clinical profiles as mood and apathy.

The PANSS component for the first pair mainly included anxiety, guilty feelings and depression (all *Z*-scores \> 1.5), with the lack of spontaneity and flow of conversation contrasting with those symptoms but less strongly (Z-score = −1.08). This represents a generally negative mood component, differing from the original design of the PANSS of positive, negative and general symptom dimensions. This mood component showed similar affective items emphasized in affective temperaments ([@bb0315]). In addition, affective temperaments patterns (the relative balance of hyperthymic vs cyclothymic-irritable-anxious-dysthymic) has been significantly associated with hopelessness, negative outcomes, and potential psychopathology ([@bb0295]). The structural brain component for this profile was mainly located in right temporal regions (including middle and superior temporal gyrus extended to inferior frontal gyrus). The negative correlation between components indicated that higher GM concentrations in right temporal regions exhibited milder mood symptoms, or lower concentrations exhibited worse mood.

The temporal regions\' deficits are common in BD and other psychiatric disorder ([@bb0010]; [@bb0120]; [@bb0410]), though its relationship with mood symptoms can be elusive, and few studies have formed a direct association between the mood symptoms and brain structure alterations ([@bb0020]; [@bb0155]; [@bb0280]; [@bb0285]; [@bb0345]). Among psychiatric symptoms, temporal regions (mostly in superior temporal gyrus) are believed to be important in thought disorders, auditory verbal hallucinations and across the positive symptom domains in psychosis ([@bb0030]; [@bb0265]; [@bb0260]; [@bb0280]; [@bb0375]), while mood symptoms are usually believed to be centered in the large regions including frontal, temporal and limbic regions ([@bb0095]; [@bb0205]; [@bb0300]). The structural brain studies emphasize the important role of multiple involvement of temporal regions especially superior temporal gyrus ([@bb0120]). Cortical thickness in right superior frontal and superior temporal has been negatively correlated with Hamilton Depression Rating Scale ([@bb0220]). In addition, cortical thickness reduction in middle temporal gyrus has been negatively correlated with the global assessment of functioning, which indicated worse overall symptoms. However, it must be pointed out that, despite these significant structure/mood symptom studies, there has been even more structural imaging research in BD which reported no correlation between structural alterations and mood symptom severity ([@bb0060]; [@bb0075]; [@bb0120]; [@bb0195]; [@bb0305]). Functional studies have provided some evidence to support the role of superior/middle temporal gyrus in mood regulations ([@bb0410]). An emotional prosody task indicated BD patients exhibited stronger activation in bilateral superior temporal gyrus and right inferior frontal gyrus compared to controls ([@bb0250]). Also, in an emotional memory task, the role of left superior temporal gyrus was highlighted ([@bb0405]). The exact role of the discovered middle/superior temporal gyrus in modulating such mood components clearly needs to be further investigated.

The PANSS component for the second pair was strongly weighted on blunted affect, emotional withdrawal, passive/apathetic social withdrawal, depression and active social avoidance, while excitement along with guilty feeling was contributing negatively. In addition to negative symptoms, this PANSS component also included all the withdrawal/avoidance items along with depression. The PANSS component here was a combination of negative and general symptoms highlighting behavioral deficits involving asociality. From SZ research, a two-factor model of the PANSS has identified anhedonia-asociality-avolition as a general motivation and pleasure (MAP) factor while alogia/blunted affect as an expressive (EXP) factor. However, asociality was not included in this model ([@bb0165]). In addition, when negative symptoms were observed across different psychiatric disorders, *apathy* was another common term to describe such motivational deficits. Moreover, previous studies using subsets of the TOP sample investigated apathy comparing Apathy Evaluation Scale (AES) and PANSS ([@bb0085]; [@bb0080]; [@bb0255]). In these studies, emotional withdrawal (N2), passive/apathetic social withdrawal (N4), and lack of spontaneity and flow of conversation (N6) were chosen to form the apathy score from PANSS to compare with AES, while N2 and N4 were chosen according to Marin\'s definition of apathy ([@bb0225]). They found the apathy items from PANSS significantly correlated with AES.

In this pICA approach we find emotional withdrawal (N2) and passive/apathetic social withdrawal (N4) along with blunted affect (N1) and depression (G6, considering depression\'s relationship with anhedonia) included in the 'apathy' or withdrawal profile. The role of active social avoidance is more complicated. Active social avoidance refers to the social avoidance caused by unwarranted fear, hostility, or distrust ([@bb0125]). Some studies argue it is weighted on positive symptoms ([@bb0380]), while others that it is weighted on depression or anxiety ([@bb0015]) or not related to the preset factors of PANSS items ([@bb0415]). We suggest active social avoidance, regardless of its cause, should be seen as part of asociality while grouped into this 'apathy' component. In addition, similar to the mood component, this 'apathy' component was also constructed beyond the original PANSS structure. In this automatic data reduction process, active social avoidance survived and weighted heavily in this component. All the PANSS items are relating to withdrawal and avoidance at the clinical observation level. This withdrawal component describes another unique clinical aspect of BD patients in TOP research. The sMRI component associated with this 'apathy' component was largely located in frontal-parietal-temporal regions with an isolated region in left supramarginal gyrus (contributing negatively).

Apathy is commonly observed in mood and psychotic disorders ([@bb0100]). This frontal-parietal-temporal circuit is also the important deficits in BD brain abnormalities ([@bb0070]; [@bb0115]; [@bb0350]). Regarding its connection to symptoms, one recent connectome study suggested the frontal-parietal circuit was able to track the positive and negative symptoms assess by PANSS, though structural connectivity was not able to predict symptom dimensions ([@bb0400]). Another interesting comparison was suggested by the BSNIP research ([@bb0040]; [@bb0160]; [@bb0235]). GM concentration was checked in these three biotypes of BSNIP study, and the concentration loss followed the same order as cognitive decline: biotype 1 showed whole brain gray matter density loss, while type 2 showed largely overlapping results with type 1, and the largest effects were found in fronto-temporal circuits, parietal cortex and cerebellum. Type 3 only showed small reductions in frontal, cingulate, and temporal regions despite their similar DSM diagnoses ([@bb0160]). Our findings show similar brain circuits as type 2, and in addition we find this pattern potentially connected with apathy symptoms in a BD sample.

Excitement, mania or aggressive are the typical positive symptoms expected in BD patients with potential behavioral effects ([@bb0045]). These positive profiles did not emerge through PANSS in this analysis. However, this result does not weaken the importance of such positive symptoms; it reflects that these symptoms might not show the strongest relationships with brain structure components as seen for negative mood or apathy. Similarly, we did not find any medication or DOI effects on PANSS or brain structures in the highlighted sMRI components. Previous studies exhibited commonly prescribed medications positively affecting brain structure through various pathways ([@bb0050]; [@bb0055]; [@bb0135]; [@bb0170]), and large scale studies found medication effects on both cortical and subcortical regions ([@bb0145]; [@bb0140]). The situation was similar for DOI though the strongest effect was found in cortical thickness ([@bb0145]). The pICA method prioritized the correlation of the PANSS and sMRI during the data reduction process of both modalities, so the components do not necessarily reflect brain regions most significantly affected by medication or DOI.

These findings have some limitations. This study employed participants with the diagnosis of bipolar spectrum disorders including bipolar I and II, and around half of patients experienced at least one lifetime psychotic episode. We made the effort to enhance the stability of the results. 10-fold validations were applied to pICA to avoid results being driven by outliners, and pICA itself was running with ICASSO to ensure stability. A final limitation is that by introducing 10 mm smoothing kernel ([@bb0105]; [@bb0340]; [@bb0365]), and using a relatively strict Z score, and cluster size to filter the structural brain, the main findings were restricted to the cortical regions.

In summary, our finding suggested BD patients showed negative mood symptom and apathy profile differing from the original PANSS subscales. Importantly, localized temporal deficits and fronto-parietal circuits were found associated with these profiles.
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[^1]: PANSS: Positive and Negative Syndrome Scale.

[^2]: Note: For both components, Z score was set \>3, and cluster volumes were set \>2 cc^3^ to retain their most significant results. Brodmann areas are listed for the peak coordinates. The directions of peak Z scores indicate whether the brain region contributed positively or negatively to the component as red for positive and blue for negative in brain maps.
